Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy

Hepatology

Volumn 26, Issue 4, 1997, Pages 1006-1011

  Guadagnino, Vincenzo ^a   Stroffolini, Tommaso ^b   Rapicetta, Maria ^b   Costantino, Angela ^b   Kondili, Loreta A ^b   Menniti Ippolito, Francesca ^b   Caroleo, Benedetto ^a   Costa, Chiara ^a   Griffo, Gianfranco ^a   Loiacono, Laura ^a   Pisani, Vincenzo ^a   Focà, Alfredo ^a   Piazza, Marcello ^c  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; VIRUS TYPING;

EID: 12644279860     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260431     Document Type: Article

References (36)

1. Chiaramonte M, Stroffolini T, Caporaso N, Coppola R, Craxì A, Gaeta GB, Sagnelli E, et al. Hepatitis C virus infection in Italy. Ital J Gastroenterol 1991;23:555-558.
2. De Bac C, Stroffolini T, Gaeta GB, Taliani G, Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. HEPATOLOGY 1994;20:1442-1449.
3. Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992;116:97-102.
4. Stroffolini T, Chiaramonte M, Tiribelli C, Villa E, Simonetti R, Rapicetta M, Stazi MA, et al. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: Relative risk and population attributable risk from a case-control study in Italy. J Hepatol 1992;16:360-363.
5. AlFaleh FZ, Ayoola EA, Aljeffry M, Alrashed R, Almofareh M, Arif M, Ramia S, et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community based study. HEPATOLOGY 1991;14:215-218.
6. Garcia-Fulgueiras A, Tormo MJ, Rodriguez T, Perez-Flores D, Chirlaque D, Navarro C. Prevalence of hepatitis B and C markers in the southeast of Spain: a community based serosurvey of 2,203 adults. Scand J Infect Dis 1996;28:17-20.
7. Xia GL, Liu CB, Cao HL, Bi SL, Zhan MV, Su CA, Nan JH. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross sectional seroepidemiologic study of hepatitis A,B,C,D, and E virus infections in China, 1992. Int Hepatol Commun 1993;74:2385-2390.
8. Tawaraya H, Ohkoshi S, Kuwana K, Watanabe M, Kamimura T, Asakura H. Epidemiologic survey and genetic analysis of endemic hepatitis C virus infection in a Japanese town with a high prevalence of hepatitis B virus carriers. J Med Virol 1995;45:367-372.
9. Romanò L, Azara M, Chiaramonte M, De Mattia D, Giammanco A, Moschen ME, Scarpa B, et al. Low prevalence of anti-HCV antibody among Italian children. Infection 1994;22:350-352.
10. D'Amelio R, Stroffolini T, Matricardi PM, Nisini R, Tosti ME, Trematerra M, Villano U, et al. Low prevalence of anti-HCV antibodies among Italian Air Force Recruits. Scand J Infect Dis 1995;27:12-14.
11. Bellentani S, Pozzato G, Mazzoran L, Crocè LS, Santini F, Crovatto M, Barbisin M, et al. HCV genotype distribution in the general population of Northern Italy. J Hepatol 1996;25(S1):145.
12. Stroffolini T, Menchinelli M, Taliani G, Dambruoso V, Poliandri G, Bozza A, Lecce R, et al. High prevalence of hepatitis C virus infection in a small central Italian town: lack of evidence of parenteral exposure. Ital J Gastroenterol 1995;27:235-238.
13. Okamoto H, Sugiyama H, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infection sources. J Gen Virol 1992;73:673-679.
14. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, et al. Classification of hepatitis C virus into six major genoptypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-2399.
15. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N, et al. Hepatitis C virus genotypes: an investigation of type specific differences in geographic origin and disease. HEPATOLOGY 1994;19:13-18.
16. Nousbaum JP, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b infection in France and Italy. Ann Intern Med 1995;122:161-168.
17. Rumi MG, Iacano OL, Mingall SA, Bernhardt XF, Chemello L, Civeira MP, Christofer F, et al. Epidemiological, clinical and therapeutic associations of hepatitis C types in Western European patients. J Hepatol 1996;24:517-524.
18. Pontisso P, Ruvoletto MG, Nicoletti M, Tisminetzk YS, Gerotto M, Levrero M, Artini M, et al. Distribution of three major hepatitis C virus genotypes in Italy. A multicenter study of 495 patients with chronic heptaitis C. J Viral Hepat 1995;2:33-38.
19. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. HEPATOLOGY 1995;21:285-290.
20. McOmish F, Yap P, Dow BC, Follett EAC, Seed C, Keller A, Cobain TJ, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. J Clin Microbiol 1994;32:884-892.
21. Shev S, Widell A, Foberg U, Fryden A, Hermodsson S, Lindh G, Lindholm A, et al. HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile. Infection 1995;23:253-257.
22. Prati D, Capelli C, Zanella A, Mozzi F, Bosoni P, Pappalettera M, Zanuso F, et al. Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology 1996; 110:178-183.
23. Abramson JH: Survey methods in community medicine. New York, Churchill Livingstone, 1983:25-28.
24. Okamoto H, Tokita M, Sakamoto M, Horikita M, Iizuka H, Mishiro S. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993;74:2385-2390.
25. Spada E, Ciccaglione AR, Dettori S, Chionne P, Kondili L, Rapicetta M. HCV genotyping in the core region: an optimization of multiple PCR. IX Triennial International Symposium on Viral Hepatitis and Liver Disease 1996:246(Abstract C171).
26. Klinbaum DG, Kupper LL, Chambless LE. Logistic regression analysis of epidemiological data. Theory and practice. Commun Statist Theory Methods 1982;71:485-547.
27. Kahn HA, Sempos CT. Statistical methods in epidemiology. New York, NY: Oxford University, 1989:506-558.
28. Chiaramonte M, Stroffolini T, Lorenzoni V, Minniti F, Conti S, Floreani, Ntakirutimana E, et al. Risk factors in community acquired hepatitis C virus chronic infection: A case control study in Italy. J Hepatol 1996; 24:129-134.
29. Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, Bruno S, et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol 1995;22:691-695.
30. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. Relationship between hepatitis C viras genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995;11:1607-1610.
31. Kaur S, Rybcki L, Bacon BR, Gollan JL, Rustgi VK, Carey WD. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: Results of the National Hepatitis Screening Survey. HEPATOLOGY 1996;24:979-986.
32. DiBisceglie AM, Goddman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. HEPATOLOGY 1991;14:969-974.
33. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
34. Alter MJ, Margolis HS, Krawczynski , Judson FN, Mares A, Alexander WJ, Hu PA, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med, 1992;327:1899-1905.
35. Seef LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HI, Iber FL, Hollinger FB, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-1911.
36. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-472.